Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: December 22, 2005
Last updated: April 15, 2008
Last verified: April 2008
Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive
Behavioral: Education
Phase 4

Study Type: Observational
Official Title: Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Resource links provided by NLM:

Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment options
  • Increase focus on COPD comorbidity

Estimated Enrollment: 1820
Estimated Study Completion Date: January 2007
Detailed Description:

Study Hypothesis:



Ages Eligible for Study:   35 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Outpatient with the diagnosis or referral diagnosis of COPD.
  • COPD must be the primary reason for this outpatient contact (for both new patients and controls).

Exclusion Criteria:

  • Any co-morbidity that hampers the diagnosis and treatment of COPD in accordance with the COPD guidelines used locally (e.g. malignant disease, dementia or sequelae of apoplexy).
  • Asthma without the presence of COPD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00268866

Sponsors and Collaborators
Boehringer Ingelheim
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
  More Information Identifier: NCT00268866     History of Changes
Other Study ID Numbers: 205.367
Study First Received: December 22, 2005
Last Updated: April 15, 2008

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Chronic Disease
Respiratory Tract Diseases
Lung Diseases, Obstructive
Disease Attributes
Pathologic Processes processed this record on May 25, 2017